Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus

Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer

(2017) Claudia Martinez-Tapia et al.   EUROPEAN JOURNAL OF CANCER

Survival Outcomes With Short-Course Radiation Therapy in Elderly Patients With Glioblastoma: Data From a Randomized Phase 3 Trial

(2017) Douglas Guedes de Castro et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline

(2017) Erik P. Sulman et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation-induced cognitive toxicity: pathophysiology and interventions to reduce toxicity in adults

(2017) Christopher Wilke et al.   NEURO-ONCOLOGY

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

(2017) James R. Perry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

(2016) Enrico Franceschi et al.   JOURNAL OF NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

(2016) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Glioblastoma in the elderly — How do we choose who to treat?

(2016) Cressida F. Lorimer et al.   Journal of Geriatric Oncology

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

(2012) Annika Malmström et al.   LANCET ONCOLOGY

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

(2012) Wolfgang Wick et al.   LANCET ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Patterns of care in elderly glioblastoma patients

(2008) Fabio M. Iwamoto et al.   ANNALS OF NEUROLOGY

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme

(2008) Angelique E. Sijben et al.   JOURNAL OF NEURO-ONCOLOGY